PLUS AN INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOPWednesday 23rd October 2013, Holiday Inn Regents Park, London, UKHTA ...
Pharmaceutical Pricing & Reimbursement 2013Day One 21st October 2013Register online at• Al...
fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 Registration & Coffee9.00 ...
Overview of workshopUnderstand the HTA World globally. Quintiles tracks100 agencies around the world to monitor andunderst...
SMi PHARMACEUTICALSFORWARD PLANNER 2013JUNERNAi & Nanotechnology5 - 6 June 2013, LondonBiobanking24 - 25 June 2013, London...
PHARMACEUTICAL PRICING & REIMBURSEMENTConference: 21 & 22 October | Holiday Inn Regents Park | LONDON, UK Workshops: 23rd ...
Upcoming SlideShare
Loading in …5

SMi Group's 19th annual Pharmaceutical Pricing & Reimbursement conference


Published on

SMi Group's 19th annual Pharmaceutical Pricing & Reimbursement conference is SMi Group's longest running conference. The Early Bird expires this Friday

Published in: Education
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

SMi Group's 19th annual Pharmaceutical Pricing & Reimbursement conference

  1. 1. PLUS AN INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOPWednesday 23rd October 2013, Holiday Inn Regents Park, London, UKHTA UncoveredWorkshop Leaders:Janice Haigh, Practice Leader, Market Access, Europe, Quintiles & Anke van Engen, Director Consulting, Quintiles8.30am - 12.30pm2013Holiday Inn Regents Park | LONDON, UKPharmaceutical Pricing& Reimbursement21st & 22ndOCTOBER• Patrick Mollon, Director Global HE&OR Critical Care,Novartis• Anne-Toni Rodgers, Global Pricing and Market Access,AstraZeneca• Peter Hertzman, Director, Bristol Myers Squibb• Martin Brown, Director, Novartis• Franz Pichler, Director, Global Public Policy, Eli Lilly & Co• Sarah Pitiluck, Senior Director, Global Pricing &Reimbursement, Alexion Pharma• Janice Haigh, Director Market Access, Quintiles• Leslie Galloway, Chairman, Ethical Medicines IndustryGroup• Kirsten Bröckers, Senior Legal Advisor, CelgeneCONFERENCE SPEAKERS INCLUDEWHY ATTEND THIS EVENT• Understand how value based pricing will affectthe U.Ks pricing market and what to expect• Discuss key market access strategies with arange of case studies including those currentlybeing developed successfully with orphan drugs• Evaluate current strategies with the new NICEnetwork reforms• See the establishment of the pan-European HTAnetwork and its current effects• Develop future cross sector market accessstrategiesSMi Presents their 19th BY 28TH JUNE AND SAVE £300 I BOOK BY 19TH JULY AND SAVE £100Register online or fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711BOOKBYJUNE28THANDSAVE£300BOOKBYJULY19thANDSAVE£100“2012 was a great demonstration of current events,2013 is set for more of the same.”
  2. 2. Pharmaceutical Pricing & Reimbursement 2013Day One 21st October 2013Register online at• Alternatively fwww.pharmaceuSupported by8.30 Registration & Coffee9.00 Chairmans Opening RemarksDonald Macarthur, Global Pharmaceutical Business Analyst,JustPharmaReportsVALUE BASED PRICING & FUTURE EFFECTS9.10 Getting ready for value-based pricing: What can we doto prepare?• Planning for value based pricing in product development• Considering a broader definition of value• Developing an understanding of the new pricing processMartin Brown, Head of Health Economics and OutcomesResearch, Novartis9.50 Value Based Pricing• Implications for PPRS• What is outside the negotiations?• How will value be measured?Leslie Galloway, Chairman, Ethical Medicines Industry Group10.30 Morning CoffeeHTA & VALUE DELIVERY11.00 Establishment of the permanent pan-European HTA network:implications for HTA and coverage decision making• Timeline and process to the establishment of the network• The role of EUnetHTA in terms of operational implementing• Key activities proposed for the network and implications ofthese activities for pharmaFranz Pichler, Director, Global Public Policy, Eli Lilly & Co11.40 The challenge of value delivery• How do global value messages translate in the localenvironment?• What types of value messages best support localnegotiations?• How do we make sure that the reimbursement priceagreed at national level becomes the realised price atlocal level?Janice Haigh, Practice Leader, Market Access, Europe,Quintiles12.20 Networking Lunch1.50 Integration of Health-Economics and Market Access in thedevelopment of innovative drugs• Value-Based Development: need and opportunities todemonstrate value• Health-Economic strategies to anticipate Market Accessneeds• Methods and Tools supporting value evidence generationPatrick Mollon, Director Global HE&OR Critical Care, Novartis2.30 New Evidence on the Effectiveness Gap; How Pharma candeliver• The current problem: case studies in COPD and cancer• International comparisons of the effectiveness gap—France,UK,Germany and Finland• Partnership with pharma and health services to delivertherapeutic resultsNick Basanquet, Professor of Health Policy, Imperial CollegeLondon3.10 Afternoon Tea3.40 No-one benefits from flying with empty planes: What optionsdo we have to improve access in oncology? Experiencesfrom Scandinavia• Patients are benefiting from many new and excitinginnovative oncology products. However, the discrepanciesbetween providers’ and payers’ expectations have still tobe resolved.• There are various contractual options tested out in reality inorder to resolve the discrepancies. What are the pros andcons with these options• Examples of the above from the Scandinavian marketsPeter Hertzman, Nordic Market Access Director,Bristol Myers Squibb4.20 Implications of requiring traditional health economicassessments when evaluating ultra-orphan drugs• Traditional cost-effectiveness analyses are not anappropriate method to evaluate ultra-orphan drugs andcan have a negative impact on patient access totreatments• Countries that require traditional economic analysesinappropriately disadvantage patients with ultra-rarediseases• Instead, review agencies should look at a combination ofother factors when evaluating such drugsSarah Pitluck, Senior Director, Global Pricing &Reimbursement, Alexion Pharmaceuticals Inc5.00 Chairmans Closing Remarks and Close of Day OneSPONSORSHIP OPPORTUNITIESOur pharmaceutical events are research-based and content-driven with regular contact with major industry personnel and cover awide range of industry sectors. For more information, please contact Alia Malick on +44 (0) 207 827 6168or email
  3. 3. fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 Registration & Coffee9.00 Chairmans Opening RemarksDonald Macathur, Global Pharmaceutical Business Analyst,JustPharmaReportsU.K. MARKET ACCESS & NICE REFORMS9.10 The new NICE and its global network• A new Leadership … a New NICE?• A UK Government Export - understand how NICEproactively shapes the Pricing & Reimbursementenvironment internationally• Plan your global responseAnne-Toni Rodgers, Global Payer Lead, AstraZeneca9.50 UK Market Access-post-change challenges• Specialised commissioning• Health informatics• Joint working• Case studyRichard Lomas, National Commissioning Manager MS,Genzyme10.30 Morning Coffee11.00 Key learnings of 2 years of AMNOG• Pricing and additional benefit• Do innovative drugs still have a chance?• Roadblocks moving forward• Case studyBertram Häussler, Director, IGES Institut11.40 Healthcare reforms in Europe — How are they effecting P&R• A revisited welfare state: between cost containment andequal access• Forward enlarged private HC expenditure• Devoluting locally HC and pharma management• Narrow price corridors, parallel trade and economicdifferentials among EU Countries• New models and schemes of P&R to face both costcontainment and equal access• Different formularies management nationally and locallyFabrizio Gianfrate, Professor of Health Economics, Universityof Ferrara12.20 Networking LunchHEALTHCARE REFORMS & EU TRANSPARENCY1.50 Pricing of pharmaceuticals in a resource constrainedenvironment• Healthcare policies in a period of recession• Policies relating to pharmaceuticals during recessionaryperiods• New initiatives in pharmaceutical pricing• The role of HTACeri Phillips, Professor of Health Economics and Head of theInstitute for Health Research, Swansea University2.30 Session reserved for CelgeneKirsten Bröckers, Senior Legal Advisor, Celgene3.10 Afternoon Tea3.40 Japan: The Land that Cost Containment Forgot• Pricing environment in Japan vs leading western countries• Price comparisons• Market entry strategies• Prospects for changeDonald Macarthur, Global Pharmaceutical Business Analyst,JustPharmaReports4.20 Reform of the EU transparency directive• The push for reform – issues not covered in the 1989Directive• The content and status of the reform proposal• Next steps – when the changes will take effect in practiceJames Killick, Partner, White & Case L L P5.00 Chairmans Closing Remarks and Close of Day TwoSupported byWant to know how you can get involved? Interested in promoting your pharmaceutical services to this market?Contact Margaret Mugema,SMi Marketing on +44 (0)20 7827 6072 or email Two Tuesday 22nd October 2013
  4. 4. Overview of workshopUnderstand the HTA World globally. Quintiles tracks100 agencies around the world to monitor andunderstand their decision making processes. Themain part of the workshop will provide a factualunderstanding of the HTA map – who are the keyagencies, from what perspective is their evaluation,what types of evidence do they require, whattypically drives HTA success or failure?The final part of the workshop will reveal somesecrets about the main HTA bodies – what are therules which are not published, which agencies arethe most influential, what you can’t learn frominterviews or ad-boards.Note: attendees from pharma companies only.Programme:8.30 Registration & Coffee9.00 Understanding the HTA map• Key agencies• Types of assessment and evaluation• Differences and similarities11.00 Break for Coffee11.30 HTA uncovered• Drivers of success and failure• What they dont print in the rules12.00 Q&A12.30 Close of workshopAbout the workshop hosts:Janice Haigh Practice Leader, Market Access,QuintilesJanice joined Quintiles Consulting in January 2012as Practice Leader for Market Access in Europe.From 2006 to December 2011, Janice was theSenior Director Pricing and Market Access forAstellas Pharma, Europe and was responsible fordevelopment and implementation of pricing andmarket access strategy for new and in marketproducts, working closely with brand teams andaffiliates price management, analysing the effectof price changes on other markets. Janice alsodesigned, implemented and managed Astellas’ssupply chain integrity program which ensured thematching of supply and demand of products inEurope. Before joining Astellas in 2006, Janiceworked in consultancy for 20 years, includingalmost 10 years at IMS Health/Cambridge PharmaConsultancy where she was responsible for leadingprojects involving pricing, parallel trade, healtheconomics and health policy. Clients includedEuropean and global pharmaceutical companiesbut also trade associations and governmentbodies such as the European Commission.HTA UncoveredHALF-DAY POST-CONFERENCE AM WORKSHOP23rd October 2013,Holiday Inn Regents Park, London8.30am - 12.30pmIn association withJanice Haigh, Practice Leader, Market Access, Europe,Quintiles &Anke van Engen, Director Consulting, Quintiles
  5. 5. SMi PHARMACEUTICALSFORWARD PLANNER 2013JUNERNAi & Nanotechnology5 - 6 June 2013, LondonBiobanking24 - 25 June 2013, LondonJULYPharmacovigilance1 - 2 July 2013, LondonCell Culture3 - 4 July 2013, LondonSEPTEMBERCancer Vaccines18 - 19 September 2013, LondonOCTOBERBiosimilars & Biobetters1 - 2 October 2013, LondonDiabetes1 - 2 October 2013, LondonOrphan Drugs14 - 15 October 2013, LondonCOPD: Novel Therapeutics andManagement Strategies16 - 17 October 2013, LondonEuropean PharmaceuticalPricing & Reimbursement21 - 22 October 2013, LondonPoint of Care Diagnostics- Market Opportunities andTechnology Trents23 - 24 October 2013, LondonNOVEMBERCell Based Assays18 - 19 November 2013, LondonClinical Trials in CNS18 - 19 November 2013, LondonDECEMBERCold Chain Distribution3 - 4 December 2013, London
  6. 6. PHARMACEUTICAL PRICING & REIMBURSEMENTConference: 21 & 22 October | Holiday Inn Regents Park | LONDON, UK Workshops: 23rd October 2013, London4 WAYS TO REGISTERFAX your booking form to +44 (0) 870 9090 712PHONE on +44 (0) 870 9090 you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email them at□ Book by 28th June to receive £300 off the conference price□ Book by 19th July to receive £100 off the conference priceEARLY BIRDDISCOUNTPayment must be made to SMi Group Ltd, and received before the event, by one ofthe following methods quoting reference P-085 and the delegate’s name. Bookingsmade within 7 days of the event require payment on booking, methods of paymentare below. Please indicate method of payment:□ UK BACS Sort Code 300009, Account 00936418□ Wire Transfer Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AUSwift (BIC): LOYDGB21013, Account 00936418IBAN GB48 LOYD 3000 0900 9364 18□ Cheque We can only accept Sterling cheques drawn on a UK bank.□ Credit Card □ Visa □ MasterCard □ American ExpressAll credit card payments will be subject to standard credit card charges.Card No: □□□□ □□□□ □□□□ □□□□Valid From □□/□□ Expiry Date □□/□□CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX cardCardholder’s Name:Signature: Date:I agree to be bound by SMis Terms and Conditions of Booking.Card Billing Address (If different from above):CONFERENCE PRICESDOCUMENTATION (Shipped 10-14 days after theI would like to attend: (Please tick as appropriate) Fee Total□ Conference & 2 Workshops £2697.00 + VAT £3236.40□ Conference & 1 Workshop £2098.00 + VAT £2517.60□ Conference only £1499.00 + VAT £1798.80□ 1 Workshop only £599.00 + VAT £718.80□ 2 Workshops only £1198.00 + VAT £1437.60Workshop A □ Workshop B □PROMOTIONAL LITERATURE DISTRIBUTION□ Distribution of your company’s promotionalliterature to all conference attendees £999.00 + VAT £1198.80GROUP DISCOUNTS AVAILABLEThe Conference fee includes refreshments, lunch, conference papers andCD ROM containing all of the presentations.I cannot attend but would like to purchase access to the following DocumentPortal/paper copy documentation: Price Total□ Access to the conference documentationon the Document Portal £499.00 + VAT £598.80□ The Conference Presentations - paper copy £499.00 - £499.00(or only £300 if ordered with the Document Portal)VATVAT at 20% is charged on the attendance fees for all delegates. VAT is also chargedon CD ROMs and Literature Distribution for all UK customers and for those EUcustomers not supplying a registration number for their own country here:_______________________PAYMENTPOST your booking form to: Events Team, SMi Group Ltd, 2nd FloorSouth, Harling House, 47-51 Great Suffolk Street, London, SE1 0BSPayment: If payment is not made at the time of booking, then an invoice will be issued and mustbe paid immediately and prior to the start of the event. If payment has not been received thencredit card details will be requested and payment taken before entry to the event. Bookings within7 days of event require payment on booking. Access to the Document Portal will not be given untilpayment has been received.Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, anotherdelegate to take your place at any time prior to the start of the event. Two or more delegates maynot ‘share’ a place at an event. Please make separate bookings for each delegate.Cancellation: If you wish to cancel your attendance at an event and you are unable to send asubstitute, then we will refund/credit 50% of the due fee less a £50 administration charge, providingthat cancellation is made in writing and received at least 28 days prior to the start of the event.Regretfully cancellation after this time cannot be accepted. We will however provide theconferences documentation via the Document Portal to any delegate who has paid but is unableto attend for any reason. Due to the interactive nature of the Briefings we are not normally able toprovide documentation in these circumstances. We cannot accept cancellations of ordersplaced for Documentation or the Document Portal as these are reproduced specifically to order.If we have to cancel the event for any reason, then we will make a full refund immediately, butdisclaim any further liability.Alterations: It may become necessary for us to make alterations to the content, speakers, timing,venue or date of the event compared to the advertised programme.Data Protection: The SMi Group gathers personal data in accordance with the UK Data ProtectionAct 1998 and we may use this to contact you by telephone, fax, post or email to tell you aboutother products and services. Unless you tick here □ we may also share your data with third partiesoffering complementary products or services. If you have any queries or want to update any ofthe data that we hold then please contact our Database Manager or visit our website quoting the URN as detailed aboveyour address on the attached letter.Unique Reference NumberOur Reference P-085Terms and Conditions of BookingDELEGATE DETAILSPlease complete fully and clearly in capital letters. Please photocopy for additional delegates.Title: Forename:Surname:Job Title:Department/Division:Company/Organisation:Email:Address:Town/City:Post/Zip Code: Country:Direct Tel: Direct Fax:Mobile:Switchboard:Signature: Date:I agree to be bound by SMis Terms and Conditions of Booking.ACCOUNTS DEPTTitle: Forename:Surname:Email:Address (if different from above):Town/City:Post/Zip Code: Country:Direct Tel: Direct Fax:VENUE Holiday Inn Regents Park, Carburton Street, London W1W 5EE□ Please contact me to book my hotelAlternatively call us on +44 (0) 870 9090 711,email: or fax +44 (0) 870 9090 712